CR8212A - OMEGA-CARBOXIARIL-DIFENIL-UREA REPLACED WITH FLUOR FOR THE TREATMENT AND PREVENTION OF DISEASES AND AFFECTIONS - Google Patents

OMEGA-CARBOXIARIL-DIFENIL-UREA REPLACED WITH FLUOR FOR THE TREATMENT AND PREVENTION OF DISEASES AND AFFECTIONS

Info

Publication number
CR8212A
CR8212A CR8212A CR8212A CR8212A CR 8212 A CR8212 A CR 8212A CR 8212 A CR8212 A CR 8212A CR 8212 A CR8212 A CR 8212A CR 8212 A CR8212 A CR 8212A
Authority
CR
Costa Rica
Prior art keywords
carboxiaril
difenil
affections
fluor
omega
Prior art date
Application number
CR8212A
Other languages
Spanish (es)
Inventor
Dumas Jacques
Boyer Stepehn
Riedl Bernd
Wilhelm Scott
Original Assignee
Bayer Pharmaceuticals Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharmaceuticals Corp filed Critical Bayer Pharmaceuticals Corp
Publication of CR8212A publication Critical patent/CR8212A/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Un compuesto de la formula (I): sales del mismo, prodrogas del mismo, metabolitos del mismo, composicones farmaceuticas que contiene dicho compuesto y el uso de dicho compuesto y dichas composiciones para tratar enfermedades mediadas por raf, VEGFR, PSGFR,p38 y flt-3.A compound of the formula (I): salts thereof, prodrugs thereof, metabolites thereof, pharmaceutical compositions containing said compound and the use of said compound and said compositions for treating diseases mediated by raf, VEGFR, PSGFR, p38 and flt -3.

CR8212A 2003-07-23 2006-01-23 OMEGA-CARBOXIARIL-DIFENIL-UREA REPLACED WITH FLUOR FOR THE TREATMENT AND PREVENTION OF DISEASES AND AFFECTIONS CR8212A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US48910203P 2003-07-23 2003-07-23

Publications (1)

Publication Number Publication Date
CR8212A true CR8212A (en) 2006-05-22

Family

ID=40565139

Family Applications (1)

Application Number Title Priority Date Filing Date
CR8212A CR8212A (en) 2003-07-23 2006-01-23 OMEGA-CARBOXIARIL-DIFENIL-UREA REPLACED WITH FLUOR FOR THE TREATMENT AND PREVENTION OF DISEASES AND AFFECTIONS

Country Status (4)

Country Link
CR (1) CR8212A (en)
GT (1) GT200400140A (en)
HN (1) HN2004000254A (en)
ZA (1) ZA200600609B (en)

Also Published As

Publication number Publication date
HN2004000254A (en) 2008-01-15
GT200400140A (en) 2005-04-11
ZA200600609B (en) 2007-05-30

Similar Documents

Publication Publication Date Title
ECSP066302A (en) OMEGA-CARBOXIARIL-DIFENIL-UREA REPLACED WITH FLUORINE FOR THE TREATMENT AND PREVENTION OF DISEASES AND AFFECTIONS
UY27882A1 (en) CHEMICAL COMPOUNDS
UY28691A1 (en) DERIVATIVES OF DIFENILAZETIDONA
UY30846A1 (en) OXINDOL DERIVATIVES REPLACED, MEDICINES THAT UNDERSTAND AND USE THEMSELVES
PA8680701A1 (en) OXINDOL DERIVATIVES
ECSP109934A (en) COMPOUND - 946
AR062841A1 (en) TREATMENT OF PAIN, DIABETES, AND DISORDERS OF THE LIPID METABOLISM
DOP2009000165A (en) DERIVATIVES OF REPLACED OXINDOL, MEDICATIONS THAT UNDERSTAND AND USE THEMSELVES
ECSP045474A (en) 1- (AMINOALQUIL) -3-SULPHONYLAZAINDOLS AS 5-HYDROXYTHYRIPTAMINE-6 LIGANDS
CO6150138A2 (en) CICLOBUTEN-1,2-DIONAS 3,4-DI-SUBSTITUTED AS CXC CHEMIOKIN RECEIVERS
CL2011000835A1 (en) Compounds derived from spiro-oxindole; sodium channel modulators; pharmaceutical composition comprising said compound; and use in the treatment of pain, depression, cardiovascular, respiratory, psychiatric diseases, among others.
ECSP088283A (en) PIRIDINE COMPOUNDS 5- (PHENYLISOXAZOLILETOXI) -TRIAZOL- 3-ILO SUBSTITUTED FOR THE TREATMENT OF NEUROLOGICAL, PSYCHIATRIC OR PAIN DISORDERS
ECSP088329A (en) NEW DIAZAESPIROALCANOS AND ITS USE FOR THE TREATMENT OF DISEASES MEDIATED BY CCR8
DK1519724T3 (en) Fredericamycin derivatives as drugs for the treatment of tumors
BRPI0412999A (en) Substituted 2-aminotetraline for depression treatment
CL2008001024A1 (en) Phthalazinone derived compounds; pharmaceutical composition comprising said compound; and use of the compound for the treatment of cardiovascular diseases, parkinson's, inflammatory diseases, multiple sclerosis, cancer, among others
UY28695A1 (en) DERIVATIVES OF DIFENILAZETIDONA
ECSP045353A (en) DERIVATIVES OF BENZOXAZINONA, ITS PREPARATION AND APPLICATION AS MEDICATIONS
UY29614A1 (en) CHEMICAL COMPOUNDS
GEP20135959B (en) Aryl piperazine and their usage as alpha2c antagonists
UY29613A1 (en) CHEMICAL COMPOUNDS VI
UY29607A1 (en) CHEMICAL COMPOUNDS
ECSP045397A (en) 6-ALQUILIDEN-BICYCLIC PENEMS AS INHIBITORS OF THE B-LACTAMASES
CL2008001990A1 (en) Compounds derived from substituted amino-quinazolines; pharmaceutical composition comprising said compound; and use of the compound for the treatment of Alzheimer's.
ATE441630T1 (en) SUBSTITUTED CYCLOPENT COMPOUNDS